News
1 minute read

MBHB Partner Kevin Noonan Authors PharmaLetter Article Entitled, “FDA seeks to accelerate pace of biosimilar drug approvals"

Kevin E. Noonan, Ph.D.October 4, 2018

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authored an October 4, 2018 PharmaLetter article entitled, “FDA seeks to accelerate pace of biosimilar drug approvals.” view the article